Ocupress Interactions
There are 217 drugs known to interact with Ocupress (carteolol ophthalmic), along with 9 disease interactions. Of the total drug interactions, 28 are major, 186 are moderate, and 3 are minor.
- View all 217 medications that may interact with Ocupress
- View Ocupress disease interactions (9)
Most frequently checked interactions
View interaction reports for Ocupress (carteolol ophthalmic) and the medicines listed below.
- Acular (ketorolac ophthalmic)
- Afrin (oxymetazoline nasal)
- Ambien (zolpidem)
- amiodarone
- Azmacort (triamcinolone)
- Azopt (brinzolamide ophthalmic)
- beclomethasone nasal
- Betagan (levobunolol ophthalmic)
- Betoptic (betaxolol ophthalmic)
- Bleph-10 (sulfacetamide sodium ophthalmic)
- carvedilol
- Combivent (albuterol / ipratropium)
- Cortisporin Otic (hydrocortisone / neomycin / polymyxin b otic)
- Coumadin (warfarin)
- Debrox (carbamide peroxide otic)
- diltiazem
- Diovan (valsartan)
- Flonase (fluticasone nasal)
- Folbic (multivitamin)
- Fosamax (alendronate)
- Iron Sulfate (ferrous sulfate)
- Isopto Hyoscine (scopolamine ophthalmic)
- Isopto Plain (hydroxypropyl methylcellulose ophthalmic)
- Januvia (sitagliptin)
- Keflex (cephalexin)
- Lasix (furosemide)
- lorazepam
- Lortab (acetaminophen / hydrocodone)
- Miochol-E (acetylcholine ophthalmic)
- Xalatan (latanoprost ophthalmic)
Ocupress disease interactions
There are 9 disease interactions with Ocupress (carteolol ophthalmic) which include:
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- myasthenia gravis
More about Ocupress (carteolol ophthalmic)
- Ocupress consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.